ライフサイエンスコーパス: platelet concentrate

1 y reduced by preabsorption with pooled human platelet concentrate.

2 levels of GF suggested to be associated with platelet concentrate.

3 atter requires transfusion of HLA-compatible platelet concentrates.

4 nological functions of leukocytes present in platelet concentrates.

5 g viruses, bacteria, and leukocytes in human platelet concentrates.

6 eloped to inactivate bacteria and viruses in platelet concentrates.

7 ed platelet-rich plasma to apheresis-derived platelet concentrates.

8 ation (18 patients), and PPV plus autologous platelet concentrate (22 patients).

9 telet-rich fibrin (PRF), a second-generation platelet concentrate, and atorvastatin (ATV), a potent m

10 derivative, platelet-derived growth factor, platelet concentrates, and fibroblast-growth factor-2.

11 PLA2 was measured in packed red blood cells, platelet concentrates, and fresh frozen plasma over the

12 tokines in the plasma fraction of transfused platelet concentrates, and leukodepletion prior to stora

13 powerful marker to determine the quality of platelet concentrates, because it reflects metalloprotei

14 Similarly, human platelet concentrates decreased their hemostatic functio

15 study, it can be concluded that PRF and PRGF platelet concentrate failed to augment clinical effects

16 nt feasibility of using UVB-irradiated human platelet concentrates for prevention of HLA alloimmuniza

17 ns were found in transfused patients, pooled platelet concentrates, fresh frozen plasma, and packed r

18 A platelet concentrate graft (PCG) was applied underneath

19 The platelet concentrate graft may be an alternative graft m

20 rial were to assess the clinical efficacy of platelet concentrate grafts (PCG) in the treatment of Mi

21 n of red blood cells and whole blood-derived platelet concentrates has been reported.

22 telet-rich fibrin (PRF), a second-generation platelet concentrate, has been the focus of intensive re

23 anufacture of buffy coat whole-blood-derived platelet concentrate have convinced the Canadian Blood S

24 Platelet-rich fibrin (PRF) is a platelet concentrate having sustained release of various

25 Storage of platelet concentrates, however, is associated with a red

26 Growing evidence shows the efficacy of platelet concentrates in periodontal therapy.

27 The topical use of platelet concentrates is recent, and its efficiency rema

28 eloped countries, bacterial contamination of platelet concentrates is the highest infectious risk in

29 Platelet concentrates may be prepared from whole blood o

30 Platelet concentrates (p = .004) were transfused less in

31 Platelet concentrate (PC) is known to contain growth fac

32 Both platelet concentrates (PC) derived from whole blood or s

33 ng bacteria, parasites, and viruses, in both platelet concentrates (PCs) and plasma.

34 40L were measured in blood components and in platelet concentrates (PCs) implicated in TRALI or contr

35 ve therapy for furcation defects, the use of platelet concentrates (PCs) in addition to open flap deb

36 hemorrhagic complications, administration of platelet concentrates, plasma, or coagulation factor con

37 or limitation, however, was the finding that platelet concentrates prepared from blood anticoagulated

38 In addition, platelet concentrates prepared from F-LR + MPR whole blo

39 a mouse model of platelet transfusion, aged platelet concentrates resulted in augmented inflammation

40 gatively affect availability and activity of platelet concentrate-suggested growth factors (GF).

41 ferentiation after treatment with TGFbeta or platelet concentrate supernatant, assessed by alpha smoo

42 let-rich fibrin (PRF) is a second-generation platelet concentrate that releases various growth factor

43 healthy donor blood, but did not increase in platelet concentrates that caused adverse transfusion re

44 sfusion of 2 fresh ABO blood group-identical platelet concentrates (therapeutic units), ongoing plate

45 nal alterations of aging platelets extend to platelet concentrates, this may hold important implicati

46 Previous studies have shown that exposure of platelet concentrates to riboflavin and light (Mirasol P

47 Extracellular mitochondria are found in platelet concentrates used for transfusion and are prese

48 he detection of a bacterial contamination of platelet concentrates was assessed using samples spiked

49 crease with filter A after the first 5 mL of platelet concentrates was filtered that returned to pref

50 One hundred sixty-six of these platelet concentrates were then transfused to 120 patien

51 randomized to receive prophylactic apheresis platelet concentrates when the platelet count was either

52 ed by PCFIA, occurs during leukodepletion of platelet concentrates with either filter A or B.